Design of Medical Devices Conference 2018 will be held at Minneapolis Convention Center in Minnesota, America from April 9 to 12. Elkem Silicones (ESI), an overseas company of BlueStar will participate and exhibit the SilbioneR Biomedical series for long-term implant and SilbioneR flexible skin adhesive for wound care and wearable devices.
The Conference was initiated by the University of Minnesota and was firstly held in 2001. It aims to increase academic and industry cooperation to promote the development of policies, research and education related to the design of medical devices, while supporting medical device education at the University of Minnesota. It is one of the world’s top-level medical device exchange platform. With extraordinary insight and leadership, the Conference continues to promote the industry development and has extensive influence in the world's medical device sector.
The SilbioneR Biomedical series exhibited by ESI is a key material for the manufacture of cardiac resynchronization therapy and implantable neurostimulation devices, with excellent physical properties and batch stability. The product is produced at the implantable silicone technology center of Bluestar Silicones, where the clean and sterile environment and advanced quality system provide reliable guarantee for the quality and performance of medical-grade silicone products.
In addition, ESI will showcase new SilbioneR flexible skin adhesive for wound care and wearable medical devices such as biosensor, which can be selectively adhered to healthy skin to avoid conglutinating the wound. Therefore, SilbioneR flexible skin adhesive can ensure that the touching and exchange of dressing will not damage the wounds, nor cause any pain.
ESI has always been dedicated to designing safer, more durable and economical medical devices for customers, helping them optimize the production process and achieve the best production results. Therefore, it is favored by many benchmarking medical devices enterprises. This exhibition not only embodies the long-term promise of ESI to the health care market, but also demonstrates the company's professional strength in the medical field.